Search Results 241-250 of 17324 for Teratogenic

1. Light Chain Amyloidosis Maintenance Evaluation - Mayo Clinic

   Any of the following because this study involves an agent that has possible genotoxic, mutagenic and teratogenic effects: · Received > 1 cycle of daratumumab ...

2. INdividualized Screening Trial of Innovative Glioblastoma Therapy (INSIGhT) - Mayo Clinic

   For this reason and because other therapeutic agents used in this trial are known to be teratogenic, women of child-bearing potential (women who are not ...

3. Nilotinib and Combination Chemotherapy in Treating Patients with Newly Diagnosed Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia or Blastic Phase Chronic Myelogenous Leukemia - Mayo Clinic

   Any of the following because this study involves investigational agent(s) whose genotoxic, mutagenic and teratogenic effects on the developing fetus and newborn ...

4. Testing an Active Form of Tamoxifen (4-hydroxytamoxifen) Delivered Through the Breast Skin to Control Ductal Carcinoma in Situ (DCIS) of the Breast - Mayo Clinic

   For this reason and because tamoxifen is known to be teratogenic, all heterosexually active women who may become pregnant must agree to use a reliable non ...

5. Testing the Addition of Radiation Therapy to the Usual Treatment (Immunotherapy With or Without Chemotherapy) for Stage IV Non-Small Cell Lung Cancer Patients Who Are PD-L1 Negative - Mayo Clinic

   Not pregnant and not nursing, because this study involves radiation as well as potentially chemotherapy which have known genotoxic, mutagenic and teratogenic ...

6. A Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Anti-tumor Activity of WSD0922-FU - Mayo Clinic

   Any of the following because this study involves an investigational agent whose genotoxic, mutagenic and teratogenic effects on the developing fetus and newborn ...

7. Breast-Conserving Surgery and Radiation Therapy in Patients with Multiple Ipsilateral Breast Cancer - Mayo Clinic

   ... teratogenic effects: Pregnant women; Nursing women; Women of childbearing potential who are unwilling to employ adequate contraception (as determined by the ...

8. Neoadjuvant dual checkpoint blockade with PD1 and LAG-3 inhibition in resectable Non-small cell lung Cancer - Mayo Clinic

   Participation eligibility · Any of the following because this study involves an investigational agent, the genotoxic, mutagenic, and teratogenic effects of which ...

9. Phase 1 Trial of ST-001 nanoFenretinide in Relapsed/​Refractory T-cell Non-Hodgkin Lymphoma - Mayo Clinic

   Pregnant women are excluded from this study because ST-001is a retinoid agent with the potential for teratogenic or abortifacient effects. Because there is ...

10. Buparlisib in Treating Patients With Relapsed or Refractory Non-Hodgkin Lymphoma - Mayo Clinic

    ... teratogenic effects on the developing fetus and newborn are unknown: Pregnant women; Nursing women; Women of childbearing potential who are unwilling to ...